KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $181.0 million.

  • Amgen's Tax Provisions rose 1677.42% to $181.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year increase of 14373.8%. This contributed to the annual value of $1.3 billion for FY2025, which is 14373.8% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Tax Provisions is $181.0 million, which was up 1677.42% from $705.0 million recorded in Q3 2025.
  • In the past 5 years, Amgen's Tax Provisions ranged from a high of $705.0 million in Q3 2025 and a low of $45.0 million during Q1 2024
  • For the 5-year period, Amgen's Tax Provisions averaged around $226.2 million, with its median value being $212.5 million (2021).
  • Per our database at Business Quant, Amgen's Tax Provisions crashed by 9251.25% in 2024 and then soared by 44000.0% in 2025.
  • Quarter analysis of 5 years shows Amgen's Tax Provisions stood at $232.0 million in 2021, then crashed by 43.1% to $132.0 million in 2022, then plummeted by 35.61% to $85.0 million in 2023, then soared by 82.35% to $155.0 million in 2024, then rose by 16.77% to $181.0 million in 2025.
  • Its last three reported values are $181.0 million in Q4 2025, $705.0 million for Q3 2025, and $136.0 million during Q2 2025.